Linda O. Narhi - Concepedia

Author

Linda O. Narhi

Also Known As

L O Narhi, L. Narhi, L. Närhi, L.O. Narhi, LINDA O. NARHI, Linda Narhi, Linda O. NARHI, Linda O. Narhi, Linda Owers Narhi

153

Publications

9.5K

Citations

H-Index

149

Concepts

All Affiliations

Amgen (United States)University of California, Los Angeles

About

Linda O. Narhi is an author at Amgen (United States) specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	63	4.9K
2	Natural Sciences	22	31	2.7K
3	Engineering	12	12	751
4	Social Sciences	4	4	100
5	Health Sciences	3	3	175

Linda O. Narhi

105

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Both Familial Parkinson's Disease Mutations Accelerate α-Synuclein Aggregation Linda O. Narhi, Stephen Wood, Shirley Steavenson, Journal of Biological Chemistry	1999	705
Characterization of a catalytically self-sufficient 119,000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus megaterium. Linda O. Narhi, Armand J. Fulco Journal of Biological Chemistry Saturated Fatty AcidsBiochemistryBioenergeticsBacteriologyChain Fatty Acids	1986	625
Identification and characterization of two functional domains in cytochrome P-450BM-3, a catalytically self-sufficient monooxygenase induced by barbiturates in Bacillus megaterium. Linda O. Narhi, Armand J. Fulco Journal of Biological Chemistry Functional DomainsMolecular BiologyMicrobial PhysiologyCytochrome P-450bm-3Chemical Biology	1987	333
Classification and Characterization of Therapeutic Antibody Aggregates Marisa K. Joubert, Quanzhou Luo, Yasser Nashed-Samuel, Journal of Biological Chemistry Immunocytochemical TechniqueImmunologyProtein AggregatesImmunotherapyProtein Purification	2011	307
Highly Aggregated Antibody Therapeutics Can Enhance the in Vitro Innate and Late-stage T-cell Immune Responses Marisa K. Joubert, Martha Hokom, Catherine M. Eakin, Journal of Biological Chemistry Autoimmune DiseaseAdaptive Immune SystemT-regulatory CellImmunologyAggregated Antibody Therapeutics	2012	261
Classification of Protein Aggregates1 Linda O. Narhi, Jeremy D. Schmit, Karoline Bechtold-Peters, Journal of Pharmaceutical Sciences BiochemistryProtein FoldingNatural SciencesMolecular BiologyProtein Aggregates1	2011	239
Oxidative Dimer Formation Is the Critical Rate-Limiting Step for Parkinson's Disease α-Synuclein Fibrillogenesis Sampathkumar Krishnan, Eva Y., Stephen Wood, Biochemistry	2002	203
Chemical Modifications in Therapeutic Protein Aggregates Generated under Different Stress Conditions Quanzhou Luo, Marisa K. Joubert, Riki Stevenson, Journal of Biological Chemistry Chemical ModificationMolecular BiologyProtein Phase SeparationChemistryProtein Aggregates	2011	197
Dimerization of the Extracellular Domain of the Erythropoietin (EPO) Receptor by EPO: One High-Affinity and One Low-Affinity Interaction John S. Philo, Kenneth H. Aoki, Tsutomu Arakawa, Biochemistry Low-affinity InteractionExtracellular DomainSedimentation EquilibriumSedimentation Equilibrium DataCellular Physiology	1996	196
The effect of carbohydrate on the structure and stability of erythropoietin. Linda O. Narhi, Tsutomu Arakawa, Kenneth H. Aoki, Journal of Biological Chemistry Protein ChemistryM Guanidine HclProtein FunctionProtein AssemblyBiochemistry	1991	195

Page 1